Trial Profile
A National, Multicentre, Open-label, Non-comparative, Non-interventional Survey Examining the Frequency and Severity of Acid Related Symptoms While Taking Nexium.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Feb 2011
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary)
- Indications Hyperchlorhydria
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 18 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Feb 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 21 Jul 2010 Actual initiation date (May 2010) added as reported by ClinicalTrials.gov.